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Abstract
Background: Recent advances in clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated
protein 9 (Cas9) genome editing have led to the use of long single-stranded DNA (lssDNA) molecules for generating
conditional mutations. However, there is still limited available data on the efficiency and reliability of this method.
Results: We generated conditional mouse alleles using lssDNA donor templates and performed extensive characterization
of the resulting mutations. We observed that the use of lssDNA molecules as donors efficiently yielded founders bearing
the conditional allele, with seven out of nine projects giving rise to modified alleles. However, rearranged alleles including
nucleotide changes, indels, local rearrangements and additional integrations were also frequently generated by this
method. Specifically, we found that alleles containing unexpected point mutations were found in three of the nine projects
analyzed. Alleles originating from illegitimate repairs or partial integration of the donor were detected in eight projects.
Furthermore, additional integrations of donor molecules were identified in four out of the seven projects analyzed by copy
counting. This highlighted the requirement for a thorough allele validation by polymerase chain reaction, sequencing and
copy counting of the mice generated through this method. We also demonstrated the feasibility of using lssDNA donors
to generate thus far problematic point mutations distant from active CRISPR cutting sites by targeting two distinct genes
(Gckr and Rims1). We propose a strategy to perform extensive quality control and validation of both types of mouse
models generated using lssDNA donors.
Conclusion: lssDNA donors reproducibly generate conditional alleles and can be used to introduce point mutations away
from CRISPR/Cas9 cutting sites in mice. However, our work demonstrates that thorough quality control of new models is
essential prior to reliably experimenting with mice generated by this method. These advances in genome editing
techniques shift the challenge of mutagenesis from generation to the validation of new mutant models.
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Background
Classical gene targeting employing embryonic stem cells
has long been the principal method to introduce com-
plex alleles into the mouse genome [1]. More recently,
microinjection of an RNA-guided engineered nuclease
(RGEN) together with a single-stranded oligodeoxynu-
cleotide (ssODN) has revolutionized our ability to direct
mutations in vivo [2]. However, clustered regularly inter-
spaced short palindromic repeat (CRISPR)/CRISPR-asso-
ciated protein 9 (Cas9)-aided knock-ins of larger
cassettes or loxP sites directly into one-cell mouse em-
bryos [3, 4] were breakthroughs that have remained
technically very challenging [5]. Equally, CRISPR/Cas9
reagents and ssODNs have become widely used for the
introduction of point mutations in one-cell embryos (see
examples in [6–8]). However, particular locations within
genomes, including sequences that are highly conserved
and/or repeated, regions with a low number or absence
of -NGG tri-nucleotides or sequences without active sin-
gle guide RNA (sgRNA) close to the target can represent
a barrier to the generation of specific mutants [9].
Miura and colleagues [10] first proposed long
single-stranded DNA (lssDNA) molecules, larger than
standard chemically synthesized oligonucleotides, as an
efficient alternative donor template for RGEN-aided
homologous recombination (HR). The authors recently
extended the method to the creation of conditional al-
leles and tag insertions, showing the generation of
sequence-perfect alleles [11]. We and others docu-
mented that CRISPR/Cas9-aided genome editing can
give rise to unexpected allele rearrangements (“illegitim-
ate repairs” [7], “KI + indels” [9, 12]); therefore, thor-
ough validation of new models is essential to ensure
reproducibility of the studies employing these models
[12–15]. However, limited data are available on unex-
pected events arising from the use of lssDNA and the
associated requirements for the quality control (QC) of
new models. With our extensive experience in the gener-
ation of conditional alleles through large-scale mouse
model production [16, 17], we have developed a strategy
for validation of these alleles.
Here, we have extended the application of lssDNA to
the generation of more conditional knock-out (cKO)
alleles directly in the embryo. We also produced point
mutations where the desired nucleotide change is remote
from active CRISPR cutting sites, which so far had proved
technically challenging with the available protocols. Al-
though not all attempts were successful, we confirm that
new designs employing lssDNA indeed facilitated mutant
production for cKOs and particular point mutations that
had previously been challenging to generate. Furthermore,
we show that novel point mutations and imperfect and/or
off-target donor integration(s) can occur in the process of
mutagenesis. This work emphasizes the importance of a
comprehensive strategy for the QC of new mutants. We
conclude that the utilization of lssDNA donor templates
shifts the challenge of mutagenesis from generation to the
validation of new mutant models.
Results
Generation of a conditional knock-out allele
Production of F0 animals
Proof of principle for the RGEN-aided generation of
conditional alleles employing two CRISPR/Cas9 cuts and
two separate ssODN templates as donors was published
in the early days of CRISPR/Cas9-aided mutagenesis [3].
However, the use of this strategy for allele generation
has not flourished in the literature in the same way as
other CRISPR-directed mutagenesis applications [18].
This is most likely because its success requires two con-
current events of homology-directed recombination oc-
curring on the same allele, which remain less frequent
than non-homologous end joining (NHEJ) events [5];
this is in keeping with our own experience of the
approach (see examples below). We therefore decided to
pilot the use of lssDNAs as a possible alternative to
ssODN donors.
As a first test case, we aimed to generate a condi-
tional allele in Syt7 by flanking the critical exon
ENSMUSE00000225700 with loxP sites (Fig. 1a). This
exon was chosen as defined by Skarnes and colleagues
[19]. Specifically, the exon is common to the majority
of coding transcripts in the gene, and its ablation re-
sults in frame-shift transcripts. Two pairs of sgRNAs
were designed, centred on each of the genomic se-
quences to be interrupted by loxP (Fig. 1a), and synthe-
sized to enhance the likelihood of simultaneous cuts on
both sides of the same allele. A lssDNA donor corre-
sponding to the floxed allele was generated as per
Miura and colleagues ([10], and see Methods). Specific-
ally, a double-stranded DNA template including a T7
transcription promoter followed by the 1149 bp se-
quence of the donor was obtained commercially (gBlock®,
Integrated DNA Technologies (IDT); Fig. 1). A lssDNA
was synthesized by in vitro transcription (IVT) and re-
verse transcription (detailed in Methods). The sgRNAs
and lssDNA (the sequences are provided in Add-
itional file 1: Table S1) were co-injected with Cas9 mRNA
into one-cell embryos. One hundred thirty-eight injected
embryos were re-implanted in pseudopregnant females.
Seventeen pups were weaned and ear biopsies taken for
screening of new alleles (the numbers are summarized in
Additional file 1: Table S2, Syt7).
Screening of F0 generation and genotyping of F1 animals
As animals of the F0 generation were likely to be mosaic,
we analyzed them by screening for the presence of the al-
lele of interest [13]. Polymerase chain reaction (PCR)
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amplicons were produced from genomic DNA with
primers flanking the homology arms and external to the
donor (Syt7 primers R1 and F1, Fig. 1a). Their analysis on
agarose showed two founders (Fig. 1b, Animals Syt7-1 and
Syt7-6) containing deletions. The PCR products from
founder animals were purified and sequenced by Sanger
sequencing. The sequencing showed that a total of 10 ani-
mals out of 17 were mutated on target (Syt7, Table 1).
Among them, five pups had indels at either or both 5′ and
3′ guide target sites. Three other animals (Syt7-1, Syt7-6
and Syt7-9) carried alleles with deletions of the sequence
flanked by the two pairs of sgRNAs corresponding to
non-cKO alleles. The remaining two mutants (Syt7-4 and
Syt7-8) were carriers of the designed cKO allele, with se-
quencing traces suggesting Syt7-8 to be homozygous and
Syt7-4 compound heterozygous with one cKO allele and
one allele including the 3′ loxP and an indel in 5′
(Additional file 2: Figure S1).
Positive founders Syt7-4 and Syt7-8 were mated to
wild-type (WT) animals, and the progeny (F1) were
analyzed. In contrast to the analysis of mosaic F0 animals,
sequencing of PCR fragments amplified from F1
individuals allowed for definitive characterization of the
edited alleles [13]. The outcome of the analysis of F1
animals by PCR and sequencing, employing the same
primers used for screening F0 animals, is summarized in
Table 2. Sequencing showed successful transmission of
the correctly mutated sequence (cKO allele) by both foun-
ders to their progeny (individuals Syt7-4.1d and Syt7-8.1c,
e, f and g).
Screening of mutants obtained by co-injection of
transcription activator-like effector nuclease (TALEN)
and ssODNs showed that random integration of
ssODNs can occur when using such a mutagenesis
approach [20], illustrating the requirement of further
validation of positive animals by a method allowing
copy counting. We therefore checked for the presence
of additional copies of the lssDNA donor sequence in
the genome of F0 and F1 animals using digital droplet
PCR (ddPCR) and a TaqMan™ assay centred on the
critical exon present in the donor sequence run against
a known two-copy reference assay (Syt7 exon 7, Dot1l
reference assay, as per [13]). Table 2 shows the copy
number of the donor sequence in each individual,
Fig. 1 Generation of a Syt7 floxed allele. a Diagrammatic representation of the genomic sequence with the Syt7 critical exon highlighted, the
corresponding template for lssDNA synthesis and the position of sgRNAs for in vivo delivery together with the primer locations used for reverse
transcription and for genotyping. Note loxP sites in the lssDNA prevent reprocessing of repaired alleles by CRISPR-Cas9 complex. Diagram shows
the process for the generation of lssDNA through in vitro transcription and reverse transcription. HA homology arm. b PCR products amplified
from genomic DNA extracted from the 17 F0 born from the microinjection session using Syt7-F1 and Syt7-R1 primers. L1 = 1 kb DNA molecular
weight ladder (thick band is 3 kb). L2 = 100 bp DNA molecular weight ladder (thick bands are 1000 and 500 bp). Sequence trace data derived
from animals Syt7-4 and Syt7-8 are displayed in Additional file 2: Figure S1.
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illustrating the presence of additional copies in some F0
(Syt7-8) and F1 individuals (Syt7-8.1c, d, g and h).
In particular, copy counting for founder Syt7-8 (which
was suggested as a potential homozygous for the cKO
allele by PCR and sequencing) also revealed additional
integrations of the lssDNA donor (close to 2.8 copies
per genome, Table 2). The copy number obtained in the
founder is not a clear integer number, which is not
impossible in a mosaic animal. Analysis of the F1 pro-
geny confirmed the presence of an additional integration
(Syt7-8.1c, d, g and h) and strongly suggested that this
event was not physically linked to the targeted allele in
the founder, as this integration could be segregated from
the mutated allele in other F1 progeny (Syt7-8.1e and f).
Copy counting of the critical exon also confirmed de-
letions of the target region in some F0 (Syt7-4) and F1
individuals (Syt7-4.1a, b and c; Syt7-8.1a). The ddPCR
analysis also showed a reduced copy number of exon 7
in F1 animals initially thought to be WT as an exon dele-
tion had not been detected by standard PCR with exter-
nal primers (Syt7-4.1a, b and c; Syt7-8.1a) Table 2. This
suggests that these animals were bearing a deletion lar-
ger than the segments flanked by the genotyping primers.
In summary, the delivery of lssDNA donor together
with CRISPR/Cas9 reagent to a modest number of
one-cell embryos produced mosaic animals that trans-
mitted a conditional allele. Some of the transmitting
progeny were excluded upon further validation steps
due to additional integrations of donor sequence.
Other conditional alleles
Production of F0 animals
The pilot was next extended to include a further eight genes
with the same design principles (Table 1 and Additional file
1: Table S2): Two sgRNAs were selected on each side of a
critical exon in the genomic sequences to be interrupted by
the loxP sites (details of sequences are given in Add-
itional file 1: Table S1, designs in Additional file 4: Figure
S3). Refining our strategy in the process of extending the
pilot, we introduced standard sequences flanking the loxP
sites in the designs, thus allowing us to re-use established
diagnostic tests for the validation of alleles (restriction
enzyme sites or LoxP-F and LoxP-R primers in
Additional file 4: Figure S3). This facilitated the analysis of
animals. CRISPR/Cas9 reagents and lssDNA were delivered
to C57BL/6NTac one-cell embryos by pronuclear injection.
Screening of F0 generation and genotyping of F1 animals
F0 and F1 animals were analyzed according to the same
strategy as that used for the Syt7 conditional allele: PCR
Table 2 Characterization of animals for the generation of a Syt7 conditional allele
Founder ID Allele type 1 Allele type 2 Allele type 3 Copy number F1 animal ID PCR and sequencing
outcome
Copy number Allele 1 Allele 2
Syt7-4 cKO 5’ NHEJ + 3’ loxP Deletionc 1.03 ± 0.07 4.1a Only WT allele
amplified
1.08 ± 0.04 WT Deletionc
4.1b Only WT allele
amplified
1.02 ± 0.04 WT Deletionc
4.1c Only WT allele
amplified
1.09 ± 0.06 WT Deletionc
4.1d Both loxP present 1.99 ± 0.08 WT cKO
Syt7-8 cKO Appears
homozygousa
Additional
insertionb
2.78 ± 0.15 8.1a Only WT allele
amplified
1.00 ± 0.07 WT Deletionc
8.1b Only WT allele
amplified
1.93 ± 0.08 WT WT
8.1c Both loxP present 2.98 ± 0.09 WT cKO + Additional
insertionb
8.1d Only WT allele
amplified
2.93 ± 0.09 WT WT + Additional
insertionb
8.1e Both loxP present 2.07 ± 0.07 WT cKO
8.1f Both loxP present 2.13 ± 0.07 WT cKO
8.1g Both loxP present 2.89 ± 0.15 WT cKO + Additional
insertionb
8.1h Only WT allele
amplified
2.90 ± 0.15 WT WT + Additional
insertionb
The table summarizes the results of screening of the F0 animals obtained for the generation of a conditional Syt7 allele and of the F1 animals
produced from the mating of F0 positive animals to WT mice. Outcomes of PCR and Sanger sequencing characterization employing the Syt7-F1 and
Syt-R1 primers external to the lssDNA donor and copy counting of the donor, where relevant, are shown. Sequencing data showing a correct
conditional allele is shown in Additional file 3: Figure S2a
aSecond legitimate repair or combined with large deletion, unclear at F0 stage
bRevealed by copy number, on or off target
cDeletion including at least one external genotyping primer site
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using primers external to the donor homology arms (or
two PCRs bridging the homology arms, depending on
PCR efficiency) and a PCR amplifying the region
flanked by the two loxP sites, all of which were ana-
lyzed by Sanger sequencing (Additional file 5: Figure
S4, Additional file 6: Figure S5, Additional file 7: Figure
S6, Additional file 8: Figure S7, Additional file 9: Figure
S8, Additional file 10: Figure S9, Additional file 11: Fig-
ure S10 and Additional file 12: Figure S11). A total of
279 F0 animals were analyzed, and 129 animals were
identified as bearing mutations. Seven out of nine pro-
jects yielded founders bearing the conditional allele,
with an additional one yielding a floxed allele with an
unwanted point mutation. One project (Rapgef5) only
yielded one founder bearing a conditional allele, that
died before mating age. Correct conditional alleles were
transmitted to the F1 generation for four out of the
seven projects where founder progeny were analyzed
(Table 1). However, in at least three out of nine pro-
jects, other alleles were detected which contained unex-
pected point mutations identified at the F0 generation
(Inpp5k project, Additional file 12: Figure S11h;
6430573F11Rik project, Additional file 13: Figure S12a;
Cx3cl1 project, Additional file 13: Figure S12b and c).
It is also noteworthy that illegitimate repairs [7] or partial
integration(s) of the donor were detected frequently (in
eight out of nine projects analyzed, see example in (Add-
itional file 12: Figure S11d), highlighting the requirement of
extensive allele validation by PCR and sequencing. These
events—point mutations, partial and/or rearranged integra-
tions—are reported as illegitimate repairs in Table 1.
Interestingly, F0 animals with exon deletions were gen-
erated in all but one project as a by-product. Whenever
null animals were required for ongoing research, these
founders were also mated (numbers in brackets, Table 1).
So far, germline transmission (GLT) of this additional al-
lele was obtained in five out of six projects where posi-
tive founders were bred.
It is noteworthy that two out of these nine projects
(Ikzf2 and Usp45) had been previously attempted employ-
ing ssODNs or plasmids without yielding founders with
conditional alleles, in contrast to subsequent attempts
with lssDNA donors (Additional file 1: Table S3).
F0 and F1 animals containing the cKO alleles were fur-
ther validated by copy counting with a TaqMan™ assay
centred on the floxed region. Importantly, copy counting
of the floxed region in combination with the outcome of
the targeted allele validation showed additional integra-
tions in four out of seven projects analyzed (Table 1).
Point mutations remote from active sgRNA cutting site
Production of F0 animals
Finally, we assessed whether the production of a point
mutation distal from an active sgRNA cutting site, the
generation of which has so far been unsuccessful by
repeated attempts using other methods, could also be
facilitated by the use of lssDNA. The first target for this
pilot was the generation of the GckrP446L point mutation
in C57BL/6NTac mouse embryos (sequence change
illustrated in Additional file 15: Figure S14). We initially
designed a strategy according to the standard approach,
employing a ssODN and one efficient and specific
sgRNA cutting as close as possible to the targeted
nucleotide. However, some factors limited options for
design, such as the close proximity of the target to the
exon-intron junction and splice sites that should not be
altered. Furthermore, the poor specificity of the target se-
quence (sequence conserved and repeated at two additional
locations in the mouse genome; GRCm38.p5:10:82265447–
82265469/12:21568953–21568975) rendered many guides
unspecific. The closest sgRNA to the target nucleotide
(sgRNA_20 (Fig. 2a)) was shown to be inactive by a
Guide-it™ assay, where the CRISPR/Cas9 nuclease activity
is assessed on a target DNA fragment in vitro (Fig. 3). This
was subsequently confirmed by the fact that no mutagen-
esis was detected in microinjection session 1 where this
sgRNA was used. Therefore, the closest efficient (as con-
firmed by Guide-it™ assay) and specific sgRNA that could
be selected was cutting 34 nt away from the targeted base
pair (sgRNA_3, Figs. 2a and 3). Thus, our next strategy
employed sgRNA_3 and a ssODN donor, although a dis-
tance larger than 30 bp between the target sequence and
the cutting site of the sgRNA can represent a barrier to the
generation of a specific point mutation [9]. In addition to
the targeted nucleotide mutation, a silent mutation was
included in the ssODN donor template in order to abolish
the protospacer adjacent motif (PAM) of the selected
sgRNA and prevent re-processing of the mutated allele by
the CRISPR/Cas9 system (Fig. 2a). The sgRNA activities
were checked in vitro (Fig. 3), and each RNA was
co-injected with Cas9 mRNA and the ssODN, as per the
designs shown in Fig. 2a and Additional file 1: Table S1.
We anticipated that generating the desired mutation
would be challenging, as the target base is a sub-optimal
34 base pairs away from sgRNA_3’s cut site. We there-
fore performed multiple injection sessions with two dif-
ferent ssODN designs (Gckrdonor_2 and Gckrdonor_3,
centred or offset towards the targeted mutation, respect-
ively; sequences in Additional file 1: Table S1) to en-
hance the likelihood of obtaining the desired point
mutation. The outcome of these microinjections was an-
alyzed by PCR and sequencing of the region of interest
in a total of 90 pups and is summarized in Table 3. Al-
though the silent mutation was detected in F0 animals
on five occasions, it was not accompanied by the muta-
tion of interest (Table 3 and example in Fig. 4a,
ssO-GckrP446L-54). Sequencing data from founders are
shown in Additional file 16.
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We subsequently designed an alternative strategy
employing a larger (339 bases) lssDNA sequence and
two sgRNAs flanking the region containing the tar-
geted nucleotide. The sgRNAs were selected to intro-
duce double-stranded breaks on each side of the target
(40 and 98 nt away in 5′ and 3′, respectively), and
their activity was checked in vitro. We consequently
selected sgRNA_5.2 and sgRNA_3.1 as they were
shown to be most active in vitro (Figs. 2b and 3). The
donor sequence was designed with 100 nt homology
arms flanking the cut sites, silent mutations that modify
the seed sequences of the selected sgRNAs to prevent
re-processing and the targeted base change (Fig. 2b). The
lssDNA was synthesized in accordance with prior experi-
ments and co-injected with Cas9 mRNA and the two
sgRNAs in a single session, the outcome of which is
shown in Table 3. Twenty-two pups were weaned, and ear
biopsies were taken to screen for new alleles.
Screening of F0 generation and genotyping of F1 animals
Primers were designed in genomic regions flanking,
but external to, the donor sequence to span the
donor integration (GckrP446L-F2 and GckrP446L-R2
primers, Additional file 1: Table S1 and Fig. 2b). PCR
Fig. 2 GckrP446L point mutation. Different designs of reagents for genome editing employing (a) oligonucleotides or (b) a lssDNA donor. Donors were
designed containing both coding (in red) and silent mutations (in black) that prevent reprocessing of engineered alleles in accordance with the selected
sgRNAs. Guide sequences are named sgRNAs. The shared colour coding of guides and donors highlights reagents injected within the same mix
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amplicons were synthesized from genomic DNA and
sequenced by Sanger sequencing. Sequencing data
from all founders are shown in Additional file 16.
Sequencing showed that 14 animals out of 22 were
mutated on target. Among them, eight individuals car-
ried the designed knock-in (KI) allele (Table 3), with se-
quencing traces suggesting that four animals were
homozygous for the KI (Fig. 4b). Three other individuals
showed illegitimately repaired alleles (Table 3 and silent
mutation only Fig. 4b).
Two of the four apparently homozygous positive F0s
(lss-GckrP446L-11, lss-GckrP446L-19) were mated to WT
animals for GLT of the mutated allele. The analysis of F1
animals (summarized in Table 4) showed the successful
transmission of the correctly mutated sequence by both
founders (i.e. lss-GckrP446L-11.1f, Fig. 4b).
Further model validation
We also checked for the presence of additional copies of
the donor sequence in the genome of F0 and F1 animals
using ddPCR and a TaqMan™ assay centred on the donor
sequence (as per [13]). Table 4 shows the copy number
of the donor sequence in each individual, illustrating a
deletion likely spanning a fragment larger than the
segments flanked by the genotyping primers (individuals
lss-GckrP446L-11.1a, b, d, e and h, Table 4). Although
both founders appeared homozygous for the point
mutation by Sanger sequencing, lss-GckrP446L-11 also
transmitted a deletion allele to its progeny, confirming
mosaicism in this individual.
We next attempted to employ lssDNA donors for the
generation of a mouse line bearing a point mutation in
the Rims1 gene, which also had not been achieved with
standard ssODN donors (Additional file 17: Figure S15
and Additional file 18: Figure S16; Additional file 1:
Table S4, 1 positive founder/155 animals born (0.6%); this
founder did not yield GLT, Additional file 1: Table S5).
The new design employing lssDNA (Additional file 17:
Figure S15) yielded founders bearing the correct mutation
at a much higher frequency (4 positive founders/39
animals born (10%) with lssDNA donors), one of which
achieved GLT of this second challenging point mutation
(Additional file 1: Tables S4 and S5; Additional file 19:
Figure S17; sequencing data in Additional file 20). Sequen-
cing data from all founders for the point mutation (with
ssODNs and lssDNA donors) are shown in
Additional file 20.
Discussion
Novel strategy for challenging point mutations
Standard methods employing chemically synthesized
oligonucleotides had not permitted the introduction of
the GckrP446L point mutation (Table 3), although
Fig. 3 Guide-it validation of the five sgRNAs synthesized for the
generation of the GckrP446L point mutation. Cas9 protein is
complexed with each sgRNA (B, D–G) and incubated with short
double-stranded DNA fragments containing the protospacer target.
Lanes A and C are controls and show the target template but no
Cas9/sgRNA complex. The reactions are analyzed for cleavage by
electrophoresis on agarose gel. L2 = 100 bp DNA molecular weight
ladder (thick bands are 1000 and 500 bp). Protospacer sequences
are detailed in Additional file 1: Table S1
Table 3 Generation of a GckrP446L point mutation
F0 with:
MS Donor type Guide ID(s) Donor ID Embryos
transferred
F0 biopsied
(birth rate)
Mutation Correct
mutation
SM only SM only and
rearranged
NHEJ
alleles
Random
integration
1 ssODN 20 Gckrdonor_20 80 12 (15%) 0 0 0 0 0 n.d.
2 ssODN 3 Gckrdonor_2 80 21 (26%) 12 0 2 2 9 n.d.
3 ssODN 3 Gckrdonor_2 70 13 (19%) 4 0 0 0 4 n.d.
4 ssODN 3 Gckrdonor_2 135 18 (13%) 9 0 2 1 7 n.d.
5 ssODN 3 Gckrdonor_2 42 10 (23%) 3 0 0 0 3 n.d.
6 ssODN 3 Gckrdonor_3 121 8 (7%) 5 0 1 1 3 n.d.
7 ssODN 3 Gckrdonor_3 112 8 (7%) 3 0 0 0 3 n.d.
1 lssDNA 5.2, 3.1 Gckr_P446L_lss 210 22 (10%) 14 8 1 2 7 0/2
The table shows the numbers of embryos and animals involved in mutagenesis attempts employing the injection of CRISPR/Cas9 reagents and oligonucleotides or
lssDNA donors. The percentage of transferred embryos yielding live animals at weaning is shown in parentheses. The outcome of these attempts is also summarized.
Note that sgRNA_20 was employed for the first microinjection session with ssODN_20 and substituted to sgRNA_3 and relevant donor ssODNs for subsequent sessions,
as it was confirmed to be inactive. Sequencing data from this project are displayed in Fig. 4 (additional raw sequencing data are provided in Additional file 16)
MS microinjection session, n.d. not determined SM silent mutation
Codner et al. BMC Biology  (2018) 16:70 Page 8 of 16
evidence of partial integration of the donor (silent muta-
tion) was recorded in five animals. This is likely due to
the distance between the available sgRNA and the target
sequence (34 bp). We have extended the pilot to a
second challenging point mutation and also found that
the use of a lssDNA donor yielded the generation and
GLT of the point mutation (Additional file 1: Tables S4
and S5; Additional file 19: Figure S17), reinforcing the
proposition that the use of lssDNA can rescue such un-
successful projects. This study is the first proof of
principle that the use of lssDNAs can lift the barrier to
the introduction of hitherto challenging point mutations
into the mouse genome, where no active and/or specific
sgRNA is available in the immediate vicinity of the target
site. Extending our capacity to generate point mutations
further away from available optimal sgRNA target sites
is of crucial importance, as it will enable the generation
of thus far challenging mutants, including those models
essential for the validation of candidate mutations causing
human disease arising from whole genome sequencing
(WGS) or quantitative trait locus (QTL) analysis [21].
Alternative methods for production of lssDNA donor
We chose IVT followed by reverse transcription as a
method to obtain lssDNAs [10]. Alternative methods
employing combined nickase and nuclease digestion of a
plasmid [22], use of a biotin-labelled primer [23], con-
version of double-stranded DNA to ssDNA by nucleases
(Guide-it™ Long ssDNA Production System, Takara) or
chemical synthesis [11] have been proposed. However,
synthesizing lssDNA donor molecules remains a chal-
lenge: the IVT-based method is both lengthy and expen-
sive; the use of nucleases can give limited yield and
requires DNA of impeccable quality; and chemical syn-
thesis is expensive and also has size limitations. It will be
Fig. 4 Screening by Sanger sequencing of animals for the generation of the GckrP446L point mutation with (a) oligonucleotides (F0 individual
ssO-GckrP446L-54) or (b) lssDNA donors (F0 individuals lss-Gckr
P446L-11 and lss-GckrP446L-10 and F1 individual lss-Gckr
P446L-11.1f). The figure shows
Sanger sequencing chromatograms of an amplicon generated with primers anchored external to the intended site of donor sequence integration as
detailed in Additional file 15: Figure S14. a ssODN donors only yielded introduction of the intended silent mutations, while (b) lssDNA yielded the
desired mutation in some individuals (F0 11 transmitting to 11.f) and only the silent mutations in others (F0 10). Note that founders appeared
homozygous (ssO-GckrP446L-54, lss-GckrP446L-11 and lss-GckrP446L-10) when analyzed by Sanger sequencing, but also could contain deletion
alleles in trans, as suggested by copy counting (lss-GckrP446L-11 in Table 4). A summary of the microinjection session outcomes is detailed in
Table 3, and raw sequencing data are provided in Additional file 16
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important to refine or replace these methods to facilitate
access to high-quality donors.
Efficiency of model generation
Many advancements in the rapidly evolving genome
editing field have been published on the basis of a small
number of experiments, and these have sometimes
proven to be difficult to reproduce [24, 25]. Our results
support the view that lssDNAs facilitate the production
of complex alleles, suggesting that the method as
described by Quadros and colleagues [11] is sufficiently
robust for reproducibility between laboratories.
Two of these projects (Ikzf2 and Usp45) were initially
attempted employing ssODNs or plasmids as donors,
but only the switch to lssDNA has yielded founders with
conditional alleles, suggesting it is a more successful
method (previous approaches and their outcomes are
summarized in Additional file 1: Table S3). We note that
other labs have encountered some successes with
ssODN donors and otherwise very similar methods for
the generation of cKOs ([3], this issue, Lanza et al. [18]).
However, the use of lssDNA as donors has proven more
efficient in our hands than that of ssODNs, when com-
pared for the generation of the same mutations (Ikzf2
conditional allele and Gckr and Rims1 point mutations).
In particular, it alleviates the challenge of integrating
both loxP sites in the same allele when generating cKOs
and facilitates the introduction of point mutations away
from active sgRNA active sites.
It is not yet clear why lssDNAs are proving to be
superior donor molecules in this context, but their
particular efficiency is likely not due to the length of
homology arms used in lssDNA donors (up to 100
bases), as much larger homologous sequences were
present in plasmid donors.
However, not all projects were successful. The efficiency
of this method is likely to be reliant on sufficiently active
sgRNAs on both sides of the sequence to be integrated
(i.e. the Acvr2b project did not yield conditional alleles or
any deletions). It is therefore prudent to check the activity
of sgRNAs in vitro and design the donor sequence accord-
ing to which sgRNAs are the most active. Also, GLT of
the floxed allele relies on the viability and fertility of mo-
saic founders, as illustrated by the failure so far of the
Rapgef5 project to yield a conditional allele. Finally, some
failures were due to unwanted single nucleotide changes
(examples in Additional file 13: Figure S12), most likely
picked up during the lssDNA generation process. It is our
prediction that some of these failures, but not all, will be
reversed by further repeat attempts.
In summary, our data support efficiency, but not all
models were achieved. Interestingly, the process also
produced exon deletion alleles as a by-product of the
generation of cKOs, allowing rapid access to null
alleles.
Mutant validation
Mutant validation was performed by PCR, employing
genomic primers external to the donor sequence and
systematic sequencing of the integration, as well as copy
counting of the donor sequence.
Table 4 Analysis of the GckrP446L project
Founder ID Allele 1 Allele 2 Allele 3 Copy number F1 animal ID PCR and sequencing
outcome
Copy
number
Allele 1 Allele 2
lss-GckrP446L-11 Legitimate
repair
Legitimate
repair
Deletionb 1.47 ± 0.11 11.1a WT 1.53 ± 0.07 WT WT?a
11.1b WT 1.03 ± 0.04 WT Deletion
11.1c Legitimate repair
and WT
1.88 ± 0.10 WT Legitimate
repair
11.1d WT 1.05 ± 0.06 WT Deletion
11.1e WT 1.01 ± 0.05 WT Deletion
11.1f Legitimate repair
and WT
1.85 ± 0.06 WT Legitimate
repair
11.1g Legitimate repair
and WT
1.85 ± 0.12 WT Legitimate
repair
11.1h WT 1.01 ± 0.05 WT Deletion
lss-GckrP446L-19 Legitimate
repair
Legitimate
repair
Deletionb 1.44 ± 0.18 19.1a Legitimate repair
and WT
1.90 ± 0.09 WT Legitimate
repair
19.1b Legitimate repair
and WT
1.81 ± 0.12 WT Legitimate
repair
The table details the results of screening of two positive F0 animals obtained for the generation of a Gckr
P446L point mutation and the
subsequent characterization of the F1 animals obtained from mating of these F0 animals to WT mice
aDeletion affecting the region recognized by the TaqMan™ assay
bRevealed by copy number
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Validation of mutated allele
We and others have previously described that imperfect
alleles can be generated when using ssODNs as donors
(“illegitimate repairs” [7], “KI + indels” [9]). Further,
rearranged alleles have also been detected when no
donor is included in the mutagenesis strategy [7, 12, 26].
Here we show that rearrangements also occur in the
presence of lssDNA donors (Table 1 and example in
Additional file 14: Figure S13). As such, the use of
lssDNA does not lessen the requirement for allele valid-
ation by full sequencing, as rearrangements (including
indels and partial integrations) may occur during the
double-strand break repair event. In addition, the syn-
thesis of lssDNA itself can be a source of errors [27], po-
tentially introducing unwanted sequence changes early
in the process that will require monitoring by full se-
quencing of the allele. The use of new high-fidelity en-
zymes (including a replacement of standard reverse
transcriptase) might contribute to reducing the fre-
quency of sequence errors in the edited alleles.
Inclusion in the donor of sequences of known primers
that are specific and efficient in PCR or restriction
enzyme sites can simplify screening for mutated loci but
does not replace QC by sequencing. Alternative methods
for validation of new alleles, involving string sequencing
for example, could further facilitate QC.
Additional integrations
Our results show that additional donor integrations are
common (five out of six projects; this was also found in
[18]). Even when there is no evidence of such an event
in the founder generation, it is essential to check for
their presence at the F1 stage, as there is a clonal event
at the point of GLT. Furthermore, if the mutant-specific
genotyping assay used in subsequent generations is
internal to the donor sequence, it will not discriminate
between on-target and unidentified additional integra-
tions. Copy counting can be performed by quantitative
PCR (qPCR) or most easily by ddPCR, employing an
assay centred on the donor that will recognize both WT
and mutant alleles (universal) or a mutation-specific
assay in correlation with sequencing of a locus-specific
amplicon (amplified with primers external to the donor).
The locations of random integrations were not identi-
fied, so it is unclear whether they were associated with
CRISPR/Cas9 off-target activity.
Standards for quality control
We found examples of sequence changes, indels, locus
rearrangements or random insertion of lssDNA donors
in all projects attempted, showing that mutagenesis
artefacts are very common. Full model validation at the
F1 stage is therefore essential, and it constitutes a
labor-intensive exercise involving the sequencing of large
or several overlapping amplicons and copy counting of
donor insertions. The need for extensive model valid-
ation is not specific to the use of lssDNA in genome
editing [9, 13, 20], but it is not alleviated by the use of
this new donor type.
Publications reporting proof-of-principle cases for using
the CRISPR/Cas9 system for genome engineering focus
on the novelty of methods and often do not include the
intricacies of QC of mutants [2, 3, 11]. However, thorough
validation of new models is essential to the reproducibility
of research employing mutated laboratory animals. This
can be a complex exercise, as genome editing can yield
many unpredicted events, both on-target and in other loci.
There are profound consequences in using mouse lines
harbouring additional mutations in ongoing research, in-
cluding misleading results, erroneous interpretations of
study and avoidable animal wastage. Therefore, the dis-
semination of good practice for QC is just as essential as
the distribution of efficient protocols for mutagenesis.
Also, an extensive validation of mouse mutants is indis-
pensable to providing a complete documentation of ani-
mals used in research [14].
Conclusion
Prior to the use of lssDNA, the reliable generation of
complex alleles and some point mutations remote from
efficacious sgRNA target sequences was out of reach.
Here, we have shown the application of lssDNA to both
the generation of cKO alleles and challenging point muta-
tions. However, the technique can also produce a variety
of artefacts: point mutations, indels, locus rearrangements
and additional donor integrations. A comprehensive mu-
tant validation strategy involving sequencing of the locus
and copy counting of the donor is therefore essential. The
utilization of lssDNA as a donor sequence lifts the barrier
to the generation of complex alleles and shifts the chal-
lenge of the exercise from the production of founders
bearing these new alleles towards the validation of these
new mutants.
Methods
sgRNAs
Guide sequence selection was carried out using the fol-
lowing online tools: CRISPOR [28] and Wellcome Trust
Sanger Institute (WTSI) Genome Editing (WGE) [29].
sgRNA sequences were selected with as few predicted
off-target events as possible, particularly on the same
chromosome as the intended modification. sgRNAs used in
this study are shown in Additional file 1: Table S1. sgRNAs
were synthesized directly from gBlock® (IDT, Skokie, IL,
USA) templates containing the T7 promoter using the
HiScribe™ T7 High Yield RNA Synthesis Kit (New England
BioLabs®, Ipswich, MA, USA) following manufacturer’s
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instructions. RNAs were purified using the MEGAclear Kit
(Ambion). RNA quality was assessed using a NanoDrop
spectrophotometer (ThermoScientific) and by electro-
phoresis on 2% agarose gel containing ethidium bromide
(Fisher Scientific). A Guide-it™ assay was performed as per
manufacturer instructions (Takara, Kyoto, Japan).
Templates for lssDNA synthesis
Templates for lssDNA synthesis were either assembled by
cloning in a plasmid or, when possible, were obtained from
IDT as a single gBlock®. Additional file 1: Table S1 details
the generation of the lssDNA employed in this study.
Donor sequences
Donor ssODNs (desalted grade) were obtained from
IDT. Donor lssDNAs were initially generated following a
method adapted from [10]. Briefly, templates for IVT
(donor sequence flanked by the T7 promoter) were
obtained as a gBlock® (IDT) or cloned in a plasmid that
was subsequently linearized. Typically, 150 ng of
double-stranded gBlock® template or 2 μg of plasmid tem-
plate was transcribed using the HiScribe T7 High Yield
RNA Synthesis Kit (New England BioLabs®). At the end of
the reaction, DNase I was added to remove the DNA
template. RNA was purified employing the MEGAclear
Transcription Clean-Up Kit (Ambion). Single-stranded
DNA was synthesized by reverse transcription from 20 μg
of RNA template employing SuperScript III Reverse Tran-
scriptase (Invitrogen), treated with RNAse H (Ambion)
and purified employing the QIAquick Gel Extraction Kit
(Qiagen, Hilden, Germany). Donor concentration was
quantified using the NanoDrop (Thermo Scientific), and
the integrity was checked on 1.5% agarose gel containing
ethidium bromide (Fisher Scientific).
Mixes for microinjection
Microinjection buffer (10 mM Tris-HCl, 0.1 mM ethyl-
enediaminetetraacetic acid (EDTA), 100 mM NaCl,
pH 7.5) was prepared and filtered through a 2-nm filter
and autoclaved. Mixes containing 100 ng/μl Cas9 mRNA
(5meC,Ψ) (TriLink BioTechnologies, San Diego, CA,
USA), 50 ng/μl gRNAs and 50 ng/μl ssODN or 50 ng/μl
lssDNA were prepared in microinjection buffer, filtered
through Costar® SpinX® Centrifuge Tube Filters (Corning)
and stored at − 80 °C until microinjection.
Mice
All animals were housed and maintained in the Mary
Lyon Centre, MRC Harwell Institute under specific-patho-
gen-free (SPF) conditions, in individually ventilated cages
adhering to environmental conditions as outlined in the
Home Office Code of Practice. Mice were euthanized by
Home Office Schedule 1 methods. Colonies established
during the course of this study are available for distribu-
tion and are detailed in Additional file 1: Table S6.
Pronuclear microinjection of zygotes
All embryos were obtained by superovulation. Pro-
nuclear microinjection was performed as per Gardiner
and Teboul [30], employing a FemtoJet (Eppendorf AG,
Hamburg, Germany) and C57BL/6NTac embryos for all
projects shown here, apart from Rims1, which was per-
formed with C57BL/6J embryos. Specifically, the injec-
tion pressure (Pi) was set between 100 and 700 hPa,
depending on the needle opening; the injection time (Ti)
was set at 0.5 s and the compensation pressure (Pc) was
set at 10 hPa. Mixes were centrifuged at high speed for a
further minute prior to microinjection. Injected embryos
were re-implanted in CD-1 pseudopregnant females.
Host females were allowed to litter and rear F0s.
Breeding for germline transmission
F0 animals where the presence of a desired allele was de-
tected were mated to WT isogenic animals to obtain F1
animals to assess the GLT of the allele of interest and
permit the definitive validation of its integrity.
Genomic DNA extraction ear biopsies
Genomic DNA from F0 and F1 animals was extracted
from ear clip biopsies using the DNA Extract All Reagents
Kit (Applied Biosystems) according to the manufacturer’s
instructions. The crude lysate was stored at − 20 °C.
PCR amplification and sequencing
New primer pairs were set up in a PCR reaction contain-
ing 500 ng genomic DNA extracted from a WT mouse,
1× Expand Long Range Buffer with 12.5 mM MgCl2
(Roche), 500 μM PCR Nucleotide Mix (dATP, dCTP,
dGTP, dTTP at 10 mM, Roche), 0.3 μM of each primer,
3% dimethyl sulfoxide (DMSO) and 1.8 U Expand Long
Range Enzyme mix (Roche) in a total volume of 25 μl.
Using a T100 thermocycler (Bio-Rad, Hercules, CA, USA),
PCRs were subjected to the following thermal conditions:
92 °C for 2 min followed by 40 cycles of 92 °C for 10 s, a
gradient of annealing temperatures between 55 and 65 °C
for 15 s and 68 °C for 1 min/kilobase and a final elong-
ation step for 10 min at 68 °C. The PCR outcome was ana-
lyzed on a 1.5–2% agarose gel, depending on the amplicon
size, and the highest efficient annealing temperature was
identified for the primer pair. If no temperature allowed
for an efficient and/or specific PCR amplification, the
assay was repeated with an increased DMSO concentra-
tion (up to 12%). Using optimized conditions as defined
above, PCRs for each project were run and an aliquot ana-
lyzed on agarose gel. The PCR products were purified
employing a QIAquick Gel Extraction Kit (Qiagen) and
sent for Sanger sequencing (Source Bioscience, Oxford,
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UK). Genotyping primers were chosen to be at least
200 bp away from the extremity of donors, depending on
available sequences for design.
Sequencing data analysis
Sequencing data were analyzed differently depending on
whether they were obtained from F0s or F1s (as per [13]).
At the F0 stage, animals were screened for evidence of the
expected change, i.e. the presence of loxP sites for condi-
tional allele projects or the presence of the expected base
change for the GckrP446L point mutation project. F0 ani-
mals should be considered mosaic animals. All F1 animals
are heterozygous containing one WT allele and one allele
to be determined, as they are obtained from mating F0 an-
imals with desired gene edits to WT animals. The F1 stage
enables definitive characterization of the new mutant.
Sub-cloning of PCR products
PCR products amplified from F0 DNA showing complex
sequencing traces were sub-cloned using a Zero-Blunt
PCR Cloning Kit (Invitrogen). The appropriate number
of clones (usually 12–24) per founder were picked and
grown overnight in accordance with the complexity of
the traces observed prior to sub-cloning. Plasmids were
isolated using a QIAprep Miniprep Kit (Qiagen) and an-
alyzed by Sanger sequencing (Source Bioscience) using
the M13R oligonucleotide or gene-specific primers.
ddPCR
Copy number variation experiments were performed as du-
plex reactions, where the sequence employed as a donor
was amplified using a fluorescein amidite (FAM)-labelled
assay (sourced from Biosearch Technologies, Petaluma,
CA, USA), in parallel with a VIC-labelled reference gene
assay (Dot1l, sourced from ThermoFisher) set at two copies
(CNV2) on the Bio-Rad QX200 ddPCR System (Bio-Rad)
as per Codner and colleagues [31]. Reaction mixes (22 μl)
contained 2 μl crude DNA lysate or 50 ng of phenol/
chloroform purified genomic DNA, 1× ddPCR Supermix
for probes (Bio-Rad), 225 nM of each primer (two primers
per assay) and 50 nM of each probe (one VIC-labelled
probe for the reference gene assay and one FAM-labelled
for the ssODN sequence assay). These reaction mixes were
loaded either into DG8 cartridges together with 70 μl drop-
let oil per sample and the droplets generated using the
QX100 Droplet Generator or loaded in plate format into
the Bio-Rad QX200 AutoDG and the droplets generated as
per the manufacturer’s instructions. Post droplet gener-
ation, the oil/reagent emulsion was transferred to a 96-well
semi-skirted plate (Eppendorf), and the samples were amp-
lified on a Bio-Rad C1000 Touch thermocycler (95 °C for
10 min, followed by 40 cycles of 94 °C for 30 s and 58 °C
for 60 s, with a final elongation step of 98 °C for 10 min,
where all temperature ramping was set to 2.5 °C/s). The
plate containing the droplet amplicons was subsequently
loaded into the QX200 Droplet Reader (Bio-Rad). Standard
reagents and consumables supplied by Bio-Rad were used,
including cartridges and gaskets, droplet generation oil and
droplet reader oil. Copy numbers were assessed using the
QuantaSoft software using at least 10,000 accepted droplets
per sample. The copy numbers were calculated by applying
Poisson statistics to the fraction of end-point positive
reactions, and the 95% confidence interval of this measure-
ment is shown.
Additional files
Additional file 1: Table S1. Sequences of reagents used in the study.
The table shows the sequences of the oligonucleotides and lssDNA
donors, primers and TaqMan assays employed in this study. LoxP sites
(for all conditional projects) and point mutations (for Gckr and Rims1
project) are underlined. Sequences added for diagnostic (for all
conditional projects except Syt7) and silent mutations (for Gckr and
Rims1 project) are shown in italics. For the plasmids, sequences flanked
by and including homology arms are shown. The ddPCR reference copy
counting assay is labelled with VIC. All other ddPCR copy counting assays
are labelled with fluorescein amidite (FAM). Copy counting assays
labelled as UNIV ddPCR assays recognize both WT and engineered alleles;
MUT ddPCR assays recognize engineered allele only. Table S2. Production
of founders for conditional alleles. The table shows the numbers of embryos
and animals involved in mutagenesis attempts employing the injection of
CRISPR/Cas9 reagents and lssDNA donors. Table S3. Generation of
conditional alleles employing different donor types. The table shows the
numbers of embryos and animals involved in mutagenesis attempts
employing the injection of CRISPR/Cas9 reagents and oligonucleotides,
plasmids or lssDNA donors. The results of the analysis of the founders
obtained from these attempts are also summarized. Table S4. Generation
of a Rims1R655H point mutation. Further genotype screening data for this
project are shown in Additional file 18: Figure S16 and Additional file 19:
Figure S17. Table S5. Analysis of the Rims1R655H project. The table details
the results of screening of five positive F0 animals obtained for the
generation of a Rims1R655H point mutation and the subsequent
characterization of the F1 animals obtained from mating of these F0 animals
to WT mice. Table S6. Nomenclature of new mouse lines established in the
course of the study. (XLS 81 kb)
Additional file 2: Figure S1. Screening by Sanger sequencing of
animals for the generation of a Syt7 conditional allele. The figure shows
the sequencing traces from PCR products amplified from founder Syt7-4
(a) and founder Syt7-8 (b) that reveal the integration of two loxP sites in
both animals. Note that Syt7-8 appears to be homozygous (a single trace
detected), while Syt7-4 appears to contain at least two different alleles.
The PCR products from which the sequence traces were derived are
shown in Fig. 1. (PNG 377 kb)
Additional file 3: Figure S2. Additional animal analysis information.
(DOCX 19408 kb)
Additional file 4: Figure S3. The figure shows the designs of reagents
employed for the generation of conditional alleles. Red triangles mark
loxP sites. RNA is transcribed in vitro from a double-stranded DNA
template containing the T7 promoter and the donor sequence. The resulting
RNA is reverse-transcribed employing a primer that is specific to the donor
sequence. Additional sequences (orange boxes, marked as universal) were
added to the design for the purpose of facilitating initial screening of animals
employing restriction enzyme sites and/or validated primer pairs, with the
exception of the Syt7 conditional allele (described in Fig. 1). (PNG 91 kb)
Additional file 5: Figure S4. Analysis of the Ikzf2 project. PCR
amplification of the genomic region of interest from (a, b) F0 animals and
(f, g) Ikzf2-2’s offspring with (a, f) Ikzf2-F3 and Ikzf2-3R2 primers (1594-bp
amplicon) and (b, g) LoxPF and LoxPR primers (906-bp amplicon) from
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biopsies. (a, b, f, g) Animals’ IDs are shown. + is positive control amplified
from an unrelated (a) WT, (b) plasmid template. Sequencing of PCR
amplicon from (c) the founder Ikzf2-2, (h) Ikzf2-2.1f and (i) Ikzf2-2.1 h with
Ikzf2-F3 and Ikzf2-3R2 primers. LoxP sequences are highlighted in blue.
(d) ID and outcome of PCR analysis of the region of interest and the
conclusion for each F0 individual. (e) ID, outcome of sequencing and copy
counting of the region of interest as well as the conclusion for each
individual of the first litter obtained by mating Ikzf2-2 with a WT mouse.
*Animal mated; **deletion not picked up by Ikzf2 PCR, likely encompassing
at least one primer sequence; ***allele detailed in Additional file 14:
Figure S13. Evidence of deletion is highlighted in blue. L1 = 1 kb
DNA molecular weight ladder (thick band is 3 kb). Sequencing data
showing a correct conditional allele are shown in Additional file 3:
Figure S2d. Sequencing data showing the presence of a deletion
allele in founders Ikzf2-4 and Ikzf2-8 are shown in Additional file 3:
Figure S2b and c. (PNG 1031 kb)
Additional file 6: Figure S5. Analysis of the Syt4 project. PCR
amplification of the genomic region of interest with (a) Syt4-F2 and
Syt4-R1 primers (2088-bp amplicon) and (b) Syt4-LoxPF and Syt4-LoxPR
primers (1395-bp amplicon) from F0 animal biopsies. (c) Sequencing of
PCR amplicon obtained from founder Syt4-29 with Syt4-F2 and Syt4-R1.
LoxP sequences are highlighted in blue. (d) ID, PCR analysis of the region
of interest and conclusion for each F0 individual are shown. *Syt4-29 was
mated for cKO allele transmission. **Syt4-37 was identified as having a
random insertion of the donor, as sequencing of the Syt4 PCR amplicon
obtained from Syt4-37 shows no loxP, suggesting a random integration
of the donor, Additional file 3: Figure S2j. (e) Details of the first litter
obtained by mating Syt4-29 with a WT mouse. ID, outcome of sequencing
and copy counting of the region of interest and the conclusion for each
individual are shown. PCR amplification of region of interest with Syt4-F2
and Syt4-R1 primers (2088-bp amplicon (f) and LoxPF and LoxPR primers
(1395-bp amplicon (g) from biopsies taken from founder Syt4-29’s offspring.
(h) Sequencing data obtained from Syt4-29.1a. (a, b, f, g) Animal IDs are
shown. + is positive control amplified from an unrelated WT (a, f). L1 = 1 kb
DNA molecular weight ladder (thick band is 3 kb). L2 = 100 bp DNA molecular
weight ladder (thick bands are 1000 and 500 bp). Sequencing data showing a
correct conditional allele are shown in Additional file 3: Figure S2k. Sequencing
data showing the transmission of a deletion allele by founder Syt4-17 are
shown in Additional file 3: Figure S2e, f and g. Sequencing data illustrating the
possible insertion of loxP in Syt-28 and the transmission of an illegitimate
repair are shown in Additional file 3: Figure S2i and j. (PNG 1045 kb)
Additional file 7: Figure S6. Analysis of the Usp45 project. The figure
shows the PCR amplification of the genomic region of interest with (a) Usp45-
F1 and Usp45-R3 primers (1440-bp amplicon) and (b) LoxPF and LoxPR
primers (741-bp amplicon) from biopsies taken from the F0 animals. (c) The
panels show the Usp45 PCR amplicon generated from the Usp45-18 can be
sequenced with LoxPF and LoxPR primers, demonstrating the presence of
loxP on locus. (d) The table details the F0 animals obtained. The ID and
outcome of PCR analysis of the region of interest as well as the conclusion for
each individual are shown. Usp45-18 was mated for cKO allele transmission.
(e) The table details three litters obtained by mating Usp45-18 with a WT
mouse. The ID, outcome of sequencing the region of interest and the
conclusion for each individual are shown. PCR amplification of region of
interest with Usp45-F1 and Usp45-R3 primers (1440-bp amplicon (f) and LoxPF
and LoxPR primers (741-bp amplicon (g) from biopsies taken from Usp45-18’s
offspring. Animal IDs are shown. + is positive control amplified from an
unrelated WT (a, f). L1 = 1 kb DNA molecular weight ladder (thick band is
3 kb). Sequencing data obtained from Usp45-18.1a and Usp45-18.1b are
shown in Additional file 3: Figure S2l and m. (a) Litter 3 died prior to biopsy
age. (b) Deletion affecting the region recognized by the TaqMan assay. (c)
Litter died prior to biopsy age. (d) Copy number counting of mutated se-
quence. n.d. = not determined. Further data are displayed in Additional file 3:
Figure S2. (PNG 618 kb)
Additional file 8: Figure S7. Analysis of the Rapgef5 project. PCR
amplification of the genomic region of interest with (a) Rapgef5-F1 and
Rapgef5-R1 primers (1365-bp amplicon) and (b) LoxPF and LoxPR primers
(724-bp amplicon) from biopsies taken from the F0 animals. (a, b) Animal IDs
are shown. + is positive control amplified from an unrelated (a) WT, (b)
conditional floxed animal. L1 = 1 kb DNA molecular weight ladder (thick
band is 3 kb). (c) Panel shows the sequencing of PCR amplicon obtained
from the Rapgef5-14 with Rapgef5-F1 and Rapgef5-R1 primers. LoxP
sequences are highlighted in blue. (d) The table details the F0 animals
obtained. The ID and outcome of PCR analysis of the region of interest and
the conclusion for each individual are shown. Founder Rapgef5-14 died
without offspring. Sequencing data showing the deletion allele identified in
Rapgef5-3 are shown in Additional file 3: Figure S2n. (PNG 587 kb)
Additional file 9: Figure S8. Analysis of the Cx3cl1 project. PCR
amplification of the genomic region of interest with (a) Cx3cl1-F1 and
Cx3cl1-R1 primers (1483-bp amplicon) and (b) LoxPF and LoxPR primers
(835-bp amplicon) from biopsies taken from the F0 animals. (c) The
panels show the sequencing of PCR amplicon obtained from animal
Cx3cl1-10 with Cx3cl1-F1 and Cx3cl1-R1. LoxP sequences are highlighted
in blue. (d) The table details the F0 animals obtained. The ID and outcome
of PCR analysis of the region of interest, as well as the conclusion for
each individual are shown. Three founders are mated for cKO allele
transmission (LoxP PCR positive and sequence of complex mosaic). PCR
amplification of region of interest with (e) Cx3cl1-F1 and Cx3cl1-R1
primers (1483-bp amplicon) and LoxPF and LoxPR primers (835-bp
amplicon) from biopsies taken from Cx3cl1-10’s offspring. (f) The table
details the first litter obtained by mating Cx3cl1-10 with a WT mouse. The
ID, outcome of sequencing the region of interest, copy counting of the
region of interest and the conclusion for each individual are shown. (g)
The panel shows an alignment of the sequencing data obtained from
Cx3cl1-10.1a. Blue 5′homology arm; orange universal sequences for
diagnostics; green critical region with exon in capitals; red loxP sites; grey
3′homology arm. (a, b, e) Animal IDs are shown. + is positive control
amplified from an unrelated (a) WT, (b) conditional floxed animal. L1 = 1 kb
DNA molecular weight ladder (thick band is 3 kb). Sequencing data
showing examples of illegitimately repaired conditional alleles are
shown in Additional file 3: Figure S2o and p. (PNG 1075 kb)
Additional file 10: Figure S9. Analysis of the 6430573F11Rik project.
PCR amplification of genomic DNA of (a) F0 animals, (f)
6430573F11Rik-11’s offspring or (i) 6430573F11Rik-28’s offspring with
(a, f) 6430573F11Rik-F3 and 6430573F11Rik-R2 (1721-bp amplicon)
and (b, f) LoxPF and LoxPR (999-bp amplicon). Sequencing of PCR
amplicons from (c) 6430573F11Rik-11 and (g) 6430573F11Rik-11.1a
with 6430573F11Rik-F3 and 6430573F11Rik-R2. LoxPs are in blue. ID,
outcome of PCR analysis and conclusion for (d) each F0 animal and
(e) the first litter obtained by mating 6430573F11Rik-11 with a WT
mouse. Two founders were mated for cKO GLT. *Mated; ⁑no
evidence of loxP in 6430573F11Rik amplicon, suggesting donor
integrated randomly (6430573F11Rik-28 sequence trace in
Additional file 3: Figure S2q). (g) Only WT sequence is found, indicating ran-
dom donor insertion. (f, i) Animal IDs are shown. + is positive control from
unrelated WT and conditional floxed animal for 6430573F11Rik and LoxP
PCR, respectively. L1 = 1 kb DNA molecular weight ladder (thick band is
3 kb). (h) First litter obtained by mating 6430573F11Rik-28 with a WT mouse.
ID, outcome of sequencing and copy counting of the region of interest and
the conclusion for each individual. (j) Sequencing of amplicons obtained
with 6430573F11Rik-F3 and 6430573F11Rik-R2 and 6430573F11Rik-28.1a.
Only WT sequence is found, indicating random donor insertion. Sequencing
of deletion allele in founder 6430573F11Rik-6, summary of analysis of F1
animals derived from 6430573F11Rik-6 and transmitted deletion allele are
shown in Additional file 3: Figure S2r, s and t. (PNG 1011 kb)
Additional file 11: Figure S10. Analysis of the Acvr2b project. The
figure shows the PCR amplification of the genomic region of interest
with (a) Acvr2b-F1 and Acvr2b-R1 primers (2178 bp) and (b) LoxPF and
LoxPR primers (1689 bp) from biopsies taken from the F0 animals. (a, b)
Animal IDs are shown. + is positive control amplified from an unrelated
(a) WT, (b) conditional floxed animal. L1 = 1 kb DNA molecular weight
ladder (thick band is 3 kb). (c) The table details the F0 animals obtained.
The ID and outcome of PCR analysis of the region of interest as well as
the conclusion for each individual are shown. (PNG 255 kb)
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Additional file 12: Figure S11. Analysis of the Inpp5k project. The
figure shows the PCR amplification of the genomic region of interest
with (a) Inpp5k-F1 and Inpp5k-R1 primers (1705-bp amplicon) and (b)
LoxPF and LoxPR primers (1194-bp amplicon) from biopsies taken from
the F0 animals. Animal IDs are shown. + is positive control amplified from
an unrelated WT and conditional floxed animal for the Inpp5k and LoxP
PCR, respectively. L1 = 1 kb DNA molecular weight ladder (thick band is
3 kb). (c) Sequencing chromatogram of PCR amplicons obtained from
Inpp5k-7 with Inpp5k-F1 and Inpp5k-R1. LoxP sequence is highlighted in
blue. (d) The table details the F0 animals obtained. The ID, outcome of
PCR analysis of the region of interest and the conclusion for each individual
are shown. Two founders are mated for cKO allele transmission (LoxP PCR
positive and sequence of complex mosaic). *Mated as loxP presence
confirmed by sequencing of Inpp5k PCR amplicon. (e) First litter obtained
by mating Inpp5k-7 and Inpp5k-8 with a WT mouse. The ID, outcome of
sequencing the region of interest and the conclusion for each individual are
shown. PCR amplification of region of interest with (f) Inpp5k-F1 and
Inpp5k-R1 primers (1705-bp amplicon) and (g) LoxPF and LoxPR primers
(1194-bp amplicon) from biopsies taken from Inpp5k-7’s and Inpp5k-8’s
offspring. Animal IDs are shown. + is positive control amplified from an
unrelated WT and conditional floxed animal for the Inpp5k and LoxP PCR,
respectively. L1 = 1 kb DNA molecular weight ladder (thick band is 3 kb).
Panels illustrate the sequencing data from amplicons obtained from Inpp5k-
7.1b (h, i, j) and Inpp5k-8.1c (k, l) genomic DNA with (h, i, k) Inpp5k-F1 and (j,
l) Inpp5k-R1 primers. (PNG 877 kb)
Additional file 13: Figure S12. Examples of unexpected point mutations
in the F0 animals obtained from the co-injection of CRISPR/Cas9 reagents
and lssDNA in 6430573F11Rik (a) and Cx3cl1 (b and c) projects. Blue 5′
homology arm; orange universal sequences for diagnostics; green critical re-
gion with exon in capitals; red loxP sites; grey 3′ homology arm.
Unexpected point mutations are detected by Sanger sequencing of
amplicons generated with primers external to the donor; (a) shows one
intronic SNP in floxed critical region, (b) shows two intronic nucleotide
changes (black arrows, grey highlight) and one coding nucleotide change
(red arrow, pink highlight) which was found associated with (c) SNP in 3’
loxP site. Mutations are highlighted on the sequence alignment (a) and seen
on the sequence chromatograms (b and c). (PNG 1332 kb)
Additional file 14: Figure S13. Unexpected outcome of CRISPR/Cas9-
aided mutagenesis. The figure illustrates an example of a rearranged
allele obtained from the co-injection of CRISPR/Cas9 reagents and
lssDNA to generate a conditional Ikzf2 allele. Panel (a) shows the de-
sign of the lssDNA donor compared to the WT sequence. HA hom-
ology arm, BP breakpoint (genomic sequence removed in the
intended floxed allele). Panel (b) shows sequencing of an F1 (Ikzf2–
2.1e) that bears a recombined allele where the critical region and a
loxP site are lost (allele with major representation) and a WT allele
(with minor representation). (PNG 309 kb)
Additional file 15: Figure S14. Design of a GckrP446L point mutation.
Figure illustrates the changes designed at the nucleotide and
proteomic levels with the mutagenesis strategy employing (a)
oligonucleotides and (b) lssDNA. Coding sequences are highlighted
in pink, engineered P446L change is highlighted in black with yellow
text, silent mutations are highlighted in grey and sgRNA sequences
are highlighted in green. Primers external to the donors employed
for mutant analysis are also shown in blue and detailed in
Additional file 1: Table S1. (PNG 1857 kb)
Additional file 16: The file contains the raw sequencing data obtained
from the founders generated for the GckrP446L point mutation. (ZIP 14449 kb)
Additional file 17: Figure S15. Design of a Rims1R655H point mutation.
The figure illustrates the changes designed at the nucleotide and
proteomic levels with the mutagenesis strategy employing (a)
oligonucleotides and (b) lssDNA. Coding sequences are translated into
protein sequences above annotated exon. Note that the region
containing Rims1 is not entirely accurate in the GRCm38 assembly. We
have re-sequenced this region prior to designing of the mutant (primers
shown in Additional file 1: Table S1). (PNG 521 kb)
Additional file 18: Figure S16. Generation of a point mutation in Rims1
with ssODN donors. (a) The table details the F0 animals obtained for generation
of Rims1 mutant with ssODN donors. The ID and outcome of sequencing the
region of interest, as well as the conclusion for each individual are shown. (b)
PCR amplification of region of interest with Rims1-F1 and Rims1-R1 primers
(241 bp) from biopsies taken from the F0 animals. Sequences of Rims1-ODN-
151 mosaic and of sub-cloned amplicons are shown in Additional file 3:
Figure S2u and v, demonstrating the presence of the desired mutation
in this animal that was therefore mated. (c) PCR amplification of region
of interest with Rims1-F1 and Rims1-R1 primers (241 bp) from biopsies
taken from Rims1-ODN-151’s offspring. Animal IDs are shown. + is
positive control amplified from an unrelated WT animal. L1 = 1 kb DNA
molecular weight (thick bands are 3 kb); L2 = 100 bp DNA molecular
weight ladder (thick bands are 1000 and 500 bp). (d) The table details
the first litter obtained by mating Rims1-ODN-151 with a WT mouse.
The ID, outcome of sequencing the region of interest and copy counting of
the region of interest as well as the conclusion for each individual are shown.
Sequencing of Rims1-ODN-151.1g is shown in Additional file 3: Figure S2w
and illustrates the failure of transmission of the desired allele. (PNG 893 kb)
Additional file 19: Figure S17. Generation of a point mutation in
Rims1 with a lssDNA donors. (a) PCR amplification of region of interest
with Rims1-F2 and Rims1-R2 primers (647 bp) from biopsies taken from
the F0 animals. Animal IDs are shown. + is positive control amplified
from an unrelated WT animal. L1 = 1 kb DNA molecular weight ladder
(thick band is 3 kb). (b) Sequencing of amplicon obtained from the
Rims1-lss-2, Rims1-lss-20, Rims1-lss-21 and Rims1-lss-36 animals: point
mutation is observed (blue highlight) when sequencing the Rims1-F2
primer. (c) The table details the F0 animals obtained for generation of
Rims1 mutant with lssDNA donors. The ID, outcome of sequencing the
region of interest and the conclusion for each individual are shown. (d)
The table details the first litter obtained by mating Rims1-lss-36 with a
WT mouse. The ID, outcome of sequencing the region of interest, copy
counting of the region of interest and conclusion for each individual
are shown. (e) PCR amplification of region of interest with Rims1-F3
and Rims1-R3 primers (647 bp) from biopsies taken from Rims-lss-36’s
offspring. Animal IDs are shown. + is a positive control amplified from
an unrelated WT animal. L2 = 100 bp DNA molecular weight ladder
(thick bands are 1000 and 500 bp). (f) Sequencing of amplicon obtained
from Rims1-lss-36.1a, legitimate repair observed (blue highlight) when
sequencing both directions (Rims1-F3 and Rims1-R3 primers). (g) Alignment
of Rims1-lss-36-1a offspring, legitimate repair aligned against WT allele.
R655H coding change highlighted in red. Grey background with red text
highlights silent mutations introduced by long donor. (PNG 1287 kb)
Additional file 20: The file contains the raw sequencing data obtained from
the founders generated for the Rims1R655H point mutation. (ZIP 21747 kb)
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